Balyasny Asset Management’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-296,903
| Closed | -$2.06M | – | 2909 |
|
|
2025
Q4 | $2.06M | Buy |
296,903
+277,527
| +1,432% | +$1.83M | ﹤0.01% | 1845 |
|
|
2025
Q3 | $125K | Sell |
19,376
-35,077
| -64% | -$240K | ﹤0.01% | 2775 |
|
|
2025
Q2 | $363K | Sell |
54,453
-107,099
| -66% | -$550K | ﹤0.01% | 2416 |
|
|
2025
Q1 | $1.05M | Buy |
161,552
+149,511
| +1,242% | +$1.07M | ﹤0.01% | 1969 |
|
|
2024
Q4 | $97.1K | Buy |
+12,041
| New | +$99.3K | ﹤0.01% | 2606 |
|
|
2024
Q3 | – | Sell |
-347,517
| Closed | -$2.42M | – | 2743 |
|
|
2024
Q2 | $2.42M | Buy |
347,517
+174,891
| +101% | +$1.32M | ﹤0.01% | 1461 |
|
|
2024
Q1 | $1.83M | Buy |
+172,626
| New | +$1.51M | ﹤0.01% | 1566 |
|
|
2023
Q3 | – | Sell |
-577,680
| Closed | -$4.62M | – | 2266 |
|
|
2023
Q2 | $4.62M | Buy |
+577,680
| New | +$4.26M | 0.01% | 1094 |
|
|
2023
Q1 | – | Sell |
-459,786
| Closed | -$2.89M | – | 2660 |
|
|
2022
Q4 | $2.89M | Sell |
459,786
-139,230
| -23% | -$972K | 0.01% | 1259 |
|
|
2022
Q3 | $4.13M | Buy |
+599,016
| New | +$4.16M | 0.01% | 1101 |
|
|
2022
Q2 | – | Sell |
-100,000
| Closed | -$1.4M | – | 2749 |
|
|
2022
Q1 | $2.29M | Sell |
100,000
-233,826
| -70% | -$5.72M | 0.01% | 1301 |
|
|
2021
Q4 | $9.22M | Buy |
+333,826
| New | +$8.94M | 0.03% | 657 |
|
|
2021
Q3 | – | Sell |
-150,635
| Closed | -$4.42M | – | 1943 |
|
|
2021
Q2 | $4.42M | Buy |
+150,635
| New | +$4.56M | 0.02% | 756 |
|
|
2021
Q1 | – | Sell |
-849,142
| Closed | -$24.9M | – | 1763 |
|
|
2020
Q4 | $17.7M | Buy |
849,142
+387,510
| +84% | +$7.23M | 0.1% | 289 |
|
|
2020
Q3 | $7.17M | Buy |
461,632
+253,071
| +121% | +$4.36M | 0.05% | 497 |
|
|
2020
Q2 | $3.81M | Buy |
+208,561
| New | +$3.68M | 0.03% | 581 |
|
|
2019
Q2 | – | Sell |
-743,679
| Closed | -$17.7M | – | 1473 |
|
|
2019
Q1 | $18.4M | Buy |
+743,679
| New | +$17.8M | 0.12% | 242 |
|
|
2018
Q2 | – | Sell |
-648,870
| Closed | -$10.3M | – | 1783 |
|
|
2018
Q1 | $10.3M | Buy |
+648,870
| New | +$12.1M | 0.04% | 520 |
|
|
2017
Q4 | – | Sell |
-405,498
| Closed | -$6.43M | – | 2057 |
|
|
2017
Q3 | $5.81M | Buy |
405,498
+229,964
| +131% | +$3.48M | 0.02% | 663 |
|
|
2017
Q2 | $3.04M | Sell |
175,534
-608,976
| -78% | -$7.3M | 0.01% | 861 |
|
|
2017
Q1 | $8.65M | Sell |
784,510
-702,927
| -47% | -$9.67M | 0.04% | 543 |
|
|
2016
Q4 | $21.6M | Buy |
1,487,437
+579,392
| +64% | +$10.6M | 0.12% | 253 |
|
|
2016
Q3 | $22.3M | Buy |
+908,045
| New | +$23.5M | 0.13% | 224 |
|
|
2016
Q2 | – | Sell |
-469,700
| Closed | -$12.4M | – | 1164 |
|
|
2016
Q1 | $12.4M | Buy |
469,700
+348,650
| +288% | +$25.8M | 0.07% | 346 |
|
|
2015
Q4 | $12.3M | Buy |
+121,050
| New | +$13.6M | 0.09% | 316 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
Balyasny Asset Management's BHC Position: Q1 2026 in Review
Balyasny Asset Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 296,903 shares — an estimated $2.06M sold.
Balyasny Asset Management first reported a position in BHC in Q4 2015 and held it in 25 quarters. The position peaked at $22.3M in Q3 2016. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- Balyasny Asset Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
- Balyasny Asset Management sold 296,903 Bausch Health shares in Q1 2026, an estimated $2.06M.
- Balyasny Asset Management first reported a position in Bausch Health in Q4 2015 and held it in 25 quarters.
- Balyasny Asset Management's Bausch Health position peaked at $22.3M in Q3 2016.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.